Saudi Arabia Endoscopy Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The saudi arabia endoscopy devices market size was valued at USD 559.32 million in 2025 and estimated to grow from USD 589.86 million in 2026 to reach USD 769.54 million by 2031, at a CAGR of 5.46% during the forecast period (2026-2031). This report is Segmented by Type of Device (Endoscopes [Rigid Endoscope, Flexible Endoscope, and More], Endoscopic Operative Devices [Suction System, Access Device, and More], and Visualization Equipment), Application (Gastroenterology, Gynecology, and More), End User (Hospitals, Ambulatory Surgery Centres, and Out-Patient Clinics). The Market Forecasts are Provided in Terms of Value (USD).

Saudi Arabia Endoscopy Devices Market Trends and Insights

Growing Preference for Minimally-Invasive Surgeries

Hospitals and private centers in Riyadh and Jeddah increasingly favor minimally invasive procedures because they shorten intensive-care stays and lower total treatment costs. Robotic heart programs at King Faisal Specialist Hospital cut average ICU time from 26 days to four, which convinces administrators to redirect capital toward upgraded endoscopic suites. The August 2025 installation of a da Vinci system at Johns Hopkins Aramco Healthcare signals broader regional adoption. Vendors must comply with Saudi FDA registration rules and ISO 13485 requirements before shipping systems. As clinical teams gain hands-on training at new vendor-run academies, procedure volumes for robotic and flexible endoscopy rise, anchoring steady equipment reorder cycles.

Rising Prevalence of GI Disorders in Saudi Arabia

Recent national studies document climbing rates of inflammatory bowel disease, colorectal cancer, and gastroesophageal reflux among Saudi adults, trends tied to dietary shifts and sedentary lifestyles. These conditions drive earlier and more frequent screening using colonoscopes and capsule endoscopes. Vision 2030 preventive-care mandates push public hospitals to expand surveillance programs, raising annual procurement of flexible endoscopes and 4K visualization towers. Private gastroenterology clinics respond by adding same-day diagnostic services, intensifying demand for high-volume reprocessing equipment. Compliance with international colorectal screening guidelines and Saudi FDA software-as-a-medical device rules shape product selection for AI polyp-detection tools.

Infection & Cross-Contamination Risks

Reusable endoscope reprocessing remains complex, and several Saudi hospitals have reported sporadic contamination alerts that slowed elective case throughput. Administrators now weigh premium single-use scopes against higher consumable bills. Automated endoscope washers with real-time tracking sensors mitigate some risk but raise capital budgets and maintenance costs. The Ministry of Health audits sterilization workflows under updated infection-control guidelines modeled on WHO protocols. Vendors offering built-in leak testing, RFID-based scope tracking, and validated cleaning cycles gain preference, yet smaller centers struggle with staff certification and costs.

Other drivers and restraints analyzed in the detailed report include:

• Expanding Healthcare Infrastructure & Private Hospital Investment
• Favorable Vision 2030 Healthcare Initiatives
• High Cost & Limited Reimbursement for Advanced Systems

Segment Analysis

Flexible endoscopes captured 52.12% of the Saudi Arabia endoscopy devices market share in 2025, underlining their indispensability for upper and lower GI procedures. The Saudi Arabia endoscopy devices market size for endoscopes is projected to climb alongside higher colorectal screening volumes and the uptake of capsule formats in remote monitoring programs. Hospitals increasingly bundle flexible scopes with automated reprocessors to meet new infection-control benchmarks, deepening vendor lock-in.

Visualization equipment enjoys the fastest 9.78% CAGR because 4K towers and AI polyp-detection software improve diagnostic accuracy and shorten procedure times. King Faisal Specialist Hospital adopted ultra-high-definition imaging in 2024 and reported an 18% rise in adenoma-detection rates, which spurred peer institutions to follow. Vendors highlight plug-and-play upgrades that retrofit existing towers, bridging budget gaps for public centers. Single-use visualization components, particularly in bronchoscopy, gain acceptance in ICUs that lack full reprocessing rooms.

Complete Report Scope:

• By Type of Device
  • Endoscopes
    • Rigid Endoscope
    • Flexible Endoscope
    • Capsule Endoscope
    • Robot-assisted Endoscope
  • Endoscopic Operative Devices
    • Irrigation / Suction System
    • Access Device
    • Wound Protector
    • Insufflation Device
    • Operative Manual Instrument
  • Visualization Equipment
• By Application
  • Gastroenterology
  • Orthopedic Surgery
  • Cardiology
  • ENT Surgery
  • Gynecology
  • Neurology
  • Urology
  • Others
• By End User
  • Hospitals
  • Ambulatory Surgery Centres
  • Office-based / Out-patient Clinics

List of Companies Covered in this Report:

• Ambu
• Apollo Endosurgery
• Boston Scientific
• Cantel Medical Corp.
• Capsovision Inc.
• Conmed
• Cook Group
• Diversatek Inc.
• EndoChoice Inc.
• FUJIFILM
• Interscope Inc.
• Jinshan Science & Technology
• Karl Storz
• Medtronic
• Olympus
• PENTAX Medical (HOYA)
• Richard Wolf
• Smiths Group
• Stryker
• Taewoong Medical Co. Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support